Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine - PubMed (original) (raw)
Affiliations
- PMID: 12101279
Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine
Andreas Ludwig et al. J Leukoc Biol. 2002 Jul.
Abstract
Dipeptidyl peptidase IV (DPP IV/CD26) is a costimulatory molecule as well as a protease highly expressed on T cells. Purified DPP IV has been recognized to inactivate peptide hormones, neuropeptides, and some chemokines by cleavage behind a proline residue at the penultimate N-terminal amino acid position. Here, we identified another substrate for DPP IV among the chemokine family: the interferon-inducible T cell alpha chemoattractant (I-TAC/CXCL11). Using a specific DPP IV inhibitor, we demonstrate that DPP IV is responsible for the cleavage of the chemokine by PHA/IL-2-treated T cells. As PHA/IL-2-treated T cells also express the CXCL11 receptor (CXCR3), we investigated whether truncation of CXCL11 would modulate its biological activity for these cells. Truncated CXCL11 [CXCL11(3-73)] had an eightfold reduced potential to bind and to regulate CXCR3, but was completely inactive in calcium flux and chemotaxis assays. However, consistent with its reduced but still considerable ability to down-regulate CXCR3, truncated CXCL11 desensitized T cell chemotaxis in response to the intact chemokine. Hence, CXCL11-induced T cell recruitment may be regulated by DPP IV-mediated proteolytic inactivation of CXCL11 and furthermore by desensitization of T cells via the degradation product CXCL11(3-73).
Similar articles
- Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G, Detheux M, Parmentier M, Durinx C, Lambeir AM, Neyts J, Liekens S, Maudgal PC, Billiau A, Van Damme J. Proost P, et al. Blood. 2001 Dec 15;98(13):3554-61. doi: 10.1182/blood.v98.13.3554. Blood. 2001. PMID: 11739156 - I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V, Moghini C, Paoletti S, Uguccioni M, Gerber B. Petkovic V, et al. J Leukoc Biol. 2004 Sep;76(3):701-8. doi: 10.1189/jlb.1103570. Epub 2004 Jun 3. J Leukoc Biol. 2004. PMID: 15178708 - CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, Lenaerts JP, Detheux M, Parmentier M, De Meester I, Scharpé S, Van Damme J. Struyf S, et al. J Immunol. 1999 Apr 15;162(8):4903-9. J Immunol. 1999. PMID: 10202035 - Dipeptidyl peptidase IV: development, design, synthesis and biological evaluation of inhibitors.
Borloo M, De Meester I. Borloo M, et al. Verh K Acad Geneeskd Belg. 1994;56(1):57-88. Verh K Acad Geneeskd Belg. 1994. PMID: 7911611 Review. - The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity.
Reinhold D, Kähne T, Steinbrecher A, Wrenger S, Neubert K, Ansorge S, Brocke S. Reinhold D, et al. Biol Chem. 2002 Jul-Aug;383(7-8):1133-8. doi: 10.1515/BC.2002.123. Biol Chem. 2002. PMID: 12437097 Review.
Cited by
- Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.
Metzemaekers M, Vanheule V, Janssens R, Struyf S, Proost P. Metzemaekers M, et al. Front Immunol. 2018 Jan 15;8:1970. doi: 10.3389/fimmu.2017.01970. eCollection 2017. Front Immunol. 2018. PMID: 29379506 Free PMC article. Review. - Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.
Hattermann K, Holzenburg E, Hans F, Lucius R, Held-Feindt J, Mentlein R. Hattermann K, et al. Cell Tissue Res. 2014 Jul;357(1):253-66. doi: 10.1007/s00441-014-1823-y. Epub 2014 Apr 26. Cell Tissue Res. 2014. PMID: 24770893 Free PMC article. - Discrimination of agonist and antagonist forms of CXCL10 in biological samples.
Casrouge A, Bisiaux A, Stephen L, Schmolz M, Mapes J, Pfister C, Pol S, Mallet V, Albert ML. Casrouge A, et al. Clin Exp Immunol. 2012 Jan;167(1):137-48. doi: 10.1111/j.1365-2249.2011.04488.x. Clin Exp Immunol. 2012. PMID: 22132893 Free PMC article. - Induced-fit mechanism for prolyl endopeptidase.
Li M, Chen C, Davies DR, Chiu TK. Li M, et al. J Biol Chem. 2010 Jul 9;285(28):21487-95. doi: 10.1074/jbc.M109.092692. Epub 2010 May 5. J Biol Chem. 2010. PMID: 20444688 Free PMC article. - Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.
Repnik U, Starr AE, Overall CM, Turk B. Repnik U, et al. J Biol Chem. 2015 May 29;290(22):13800-11. doi: 10.1074/jbc.M115.638395. Epub 2015 Apr 1. J Biol Chem. 2015. PMID: 25833952 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous